Galectin-3, Serum
Also known as: GALECTIN
Use
The Galectin-3, Serum test is used for prognostication in heart failure. It complements the prognostic value of N-terminal pro-brain natriuretic peptide (NT-proBNP). An elevated concentration of galectin-3 is associated with increased cardiovascular risk and adverse outcomes in patients with heart failure. It assists in the medical management of such patients, although decisions should rely primarily on clinical findings.
Special Instructions
The test has been approved by the New York State Department of Health, indicating adherence to regulatory standards. It is crucial to note that plasma specimens or visibly hemolyzed specimens are unacceptable for this test, and repeated freeze/thaw cycles should be avoided to ensure accuracy.
Limitations
The interpretation of the Galectin-3, Serum test results should not be the sole basis for managing heart failure. Instead, it should complement clinical findings. The method used is Quantitative Enzyme-Linked Immunosorbent Assay (ELISA), and results are subject to the limitations inherent in this methodology. Factors such as sample handling, collection time, and patient's physiological conditions may influence the results.
New York Approved
Methodology
Immunoassay (ELISA)
Biomarkers
LOINC Codes
- 83099-2
Result Turnaround Time
1-8 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1 mL
Minimum Volume
0.2 mL
Container
Plain Red
Collection Instructions
Allow specimen to clot completely at room temperature. Separate from cells ASAP or within 2 hours of collection.
Storage Instructions
Frozen
Causes for Rejection
Plasma. Visibly hemolyzed specimens
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 4 months |